Yiheng Capital Management’s Beam Therapeutics BEAM Stock Holding History

Yiheng Capital Management’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$725K	Hold	21,126	–	–	0.25%	26
2026 Q1	$503K	Hold	21,126	–	–	0.22%	23
2025 Q4	$586K	Sell	21,126 -47,932	-69%	-$1.22M	0.12%	22
2025 Q3	$1.68M	Hold	69,058	–	–	0.25%	24
2025 Q2	$1.17M	Hold	69,058	–	–	0.11%	22
2025 Q1	$1.35M	Sell	69,058 -357,044	-84%	-$9.35M	0.13%	21
2024 Q4	$10.6M	Sell	426,102 -337,658	-44%	-$8.62M	0.41%	16
2024 Q3	$18.7M	Sell	763,760 -81,740	-10%	-$2.11M	0.96%	12
2024 Q2	$19.8M	Hold	845,500	–	–	1.6%	16
2024 Q1	$27.9M	Hold	845,500	–	–	1.55%	12
2023 Q4	$23M	Buy	845,500 +285,000	+51%	+$7.08M	1.33%	15
2023 Q3	$13.5M	Buy	560,500 +96,700	+21%	+$2.59M	0.69%	23
2023 Q2	$14.8M	Hold	463,800	–	–	0.8%	19
2023 Q1	$14.2M	Hold	463,800	–	–	0.56%	22
2022 Q4	$18.1M	Buy	463,800 +100,000	+27%	+$4.48M	0.8%	19
2022 Q3	$17.3M	Hold	363,800	–	–	1.07%	19
2022 Q2	$14.1M	Buy	363,800 +340,400	+1,455%	+$13.5M	0.81%	26
2022 Q1	$1.34M	Buy	+23,400	New	+$1.53M	0.06%	32

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Yiheng Capital Management's BEAM Position: Q2 2026 in Review

Yiheng Capital Management held its Beam Therapeutics (BEAM) position steady in Q2 2026 at 21,126 shares worth $725K. The position accounts for 0.25% of the portfolio, ranked #26.

Yiheng Capital Management first reported a position in BEAM in Q1 2022 and has held it in 18 quarters since. The position peaked at $27.9M in Q1 2024. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Yiheng Capital Management held 21,126 shares of Beam Therapeutics worth $725K as of Q2 2026.
Yiheng Capital Management left its Beam Therapeutics share count unchanged in Q2 2026.
Beam Therapeutics made up 0.25% of Yiheng Capital Management's portfolio in Q2 2026, its #26 holding.
Yiheng Capital Management first reported a position in Beam Therapeutics in Q1 2022 and has held it in 18 quarters since.
Yiheng Capital Management's Beam Therapeutics position peaked at $27.9M in Q1 2024.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Yiheng Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.